1-4 of 4
Coleen Bejot, MSN
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ricer (Rituximab, Ifosfamide, Carboplatin, Etoposide, Revlimid) Is Well-Tolerated Salvage Regimen in First Relapse/Primary Refractory DLBCL Allowing Consolidation with Autologous Stem Cell Transplant

Tatyana Feldman, MD, Anthony R Mato, MD, Michele L. Donato, MD, Scott D Rowley, MD, Stuart L. Goldberg, MD, Carolanne Carini, RN, Marisa Valentinetti, RN, Judith Smith, RN, Gabriella Gadaleta, RN, APN-C, Coleen Bejot, MSN, NP-C, Susan Stives, APN, Mary Timberg, RN, MSN, OCN, NP-C, Ewelina A Protomastro, BA, Joshua R. Richter, MD, David H. Vesole, MD, PhD, Andrew L Pecora, MD, David S. Siegel, MD, PhD, Andre Goy, MD
Journal: Blood
Blood (2012) 120 (21): 3710.
https://doi.org/10.1182/blood.V120.21.3710.3710
Published: 2012
Journal Articles

Dose-Intensive (R-HCVAD) and High Dose Therapy (ASCT) Frontline Strategies More Than Double PFS Over Standard Therapy in MCL Patients

Anthony R Mato, MD, Ewelina A Protomastro, BA, Tania Zielonka, RDC, Tatyana Feldman, MD, Scott D Rowley, MD, Michele L Donato, MD, Andrew L Pecora, MD, Pritish K. Bhattacharyya, MD, Mary Timberg, RN, MSN, OCN, NP-C, Susan Stives, APN, Gabriella Gadaleta, RN, APN-C, Coleen Bejot, MSN, NP-C, Andre Goy, MD
Journal: Blood
Blood (2012) 120 (21): 3658.
https://doi.org/10.1182/blood.V120.21.3658.3658
Published: 2012
Journal Articles

Feasibility and Outcome of High Dose Therapy Followed by Autologous Stem Cell Transplantation in Relapsed/Refractory Lymphoma in the Geriatric Population

Anthony R Mato, MD, Andre Goy, MD, Kathryn Waksmundzki, BS, Tatyana Feldman, MD, Tania Zielonka, RDC, Ewelina A Protomastro, BA, Coleen Bejot, MSN, NP-C, Gabriella Gadaleta, RN, APN-C, Scott D Rowley, MD, Michele L Donato, MD, Andrew L Pecora, MD, Katherine Facchin, RN, John P. Leonard, MD, Richard R. Furman, MD, Jia Ruan, MD, PhD, Tsiporah B Shore, Usama Gergis, MD, Morton Coleman, MD, Rebecca Elstrom, MD
Journal: Blood
Blood (2012) 120 (21): 4269.
https://doi.org/10.1182/blood.V120.21.4269.4269
Published: 2012
Journal Articles

R-HCVAD/R-MTX-Arac (R-HCVAD) Overcomes Risk Features Associated with Inferior Outcomes In the Treatment of Newly Diagnosed, High-Risk Diffuse Large B-Cell Lymphoma (DLBCL).

Anthony R Mato, MD, Tatyana Feldman, MD, Tania Zielonka, Pritish K. Bhattacharyya, MD, Alexandria Campaiola, BSN, Rina P Shah, BA, Maria Rosario, Coleen Bejot, MSN, Susan Stives, MSN, Mary Curtin, MSN, Rosalba Vicioso, BA, Stuart L Goldberg, MD, Andrew L Pecora, MD, Andre Goy, MD
Journal: Blood
Blood (2010) 116 (21): 1782.
https://doi.org/10.1182/blood.V116.21.1782.1782
Published: 2010